GMED vs. ALGN

In the year-to-date period, GMED achieves a 53.46% return, which is significantly higher than ALGN's -22.38% return. Over the past 10 years, GMED has underperformed ALGN with an annualized return of 12.98%, while ALGN has yielded a comparatively higher 14.14% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Globus Medical, Inc. (GMED) and Align Technology, Inc. (ALGN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current GMED Sharpe Ratio is 1.90, which is higher than the ALGN Sharpe Ratio of -0.50. The chart below compares the historical Sharpe Ratios of GMED and ALGN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither GMED nor ALGN has paid dividends to shareholders.

The maximum GMED drawdown since its inception was -47.91%, smaller than the maximum ALGN drawdown of -92.80%. Use the drawdown chart below to compare losses from any high point for GMED and ALGN. For additional features, visit the drawdowns tool.

The current volatility for Globus Medical, Inc. (GMED) is 5.19%, while Align Technology, Inc. (ALGN) has a volatility of 13.19%. This indicates that GMED experiences smaller price fluctuations and is considered to be less risky than ALGN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Globus Medical, Inc. and Align Technology, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.